4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-21-003129
Options or other derivatives
- Chief Operating Officer acquired 1,329,528 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Bertrand William C JR Chief Operating Officer | 2021-01-11 | Grant or award · Option to purchase Ordinary Shares | +1,086,816 | 1,086,816 | D | ||
| Bertrand William C JR Chief Operating Officer | 2021-01-11 | Grant or award · Option to purchase Ordinary Shares | +242,712 | 242,712 | D | ||
Loading xslF345X03/tm212800-1_4seq1.xml…